Matt Abernethy

Chief Financial Officer

Chief Financial Officer at NEUROCRINE BIOSCIENCES INC, filing insider transactions on 2026-09-14.

Total Purchases

—

0 transactions

Total Sales

$363K

1 transaction

Companies Traded

1 total filings

Active Since

2026-09-14

Last: 2026-09-14

Companies

NEUROCRINE BIOSCIENCES INC

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-14	NBIX	Sale	2,311	$157.20	$363K	42.8K	SEC ↗